Vascular Neurocognitive Disorder
Resources for Patients and Caregivers
Vascular neurocognitive disorder is a condition characterized by disruptions in the brain’s blood supply that lead to impairment of one or more aspects of a person’s conscious brain functions.
Wiki Number: 56-Vascular Neurocognitive Disorder
Normal Aging, Mild Cognitive Impairment, and Dementia
Amazon or Library Books: Dementia Home Care
Click the book to link or order from Amazon.
Support Group: dementiasociety.org; 800-336-3684
(Dementia Society of America)
Resources for Physicians, Counselors and Researchers
4 CURRENT ARTICLES
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Atrial fibrillation and dementia: not everything is clear…by Tatiana Mazzoli on November 27, 2023
The prevalence of dementia is ever increasing, as well as the prevalence of atrial fibrillation (AF). Several studies and systematic reviews evaluated the association between AF and dementia, highlighting an increased risk for dementia (with odds ratios from 1.4 to 1.6), with robust results in patients with previous stroke. In fact, not only vascular dementia, but also Alzheimer's disease seems more frequent in patients with AF, even though the very high heterogeneity of the results does not...
- Innate Sleep Apnea in Spontaneously Hypertensive Rats Is Associated With Microvascular Rarefaction and Neuronal Loss in the preBötzinger Complexby Reno Roberts on November 27, 2023
CONCLUSIONS: Therefore, we postulate that hypertension induces SA through vascular damage in the respiratory column, culminating in neuronal loss in the inspiratory oscillator. This induction of SA, which, in turn, will independently exacerbate hypertension and neural inflammation, increases the rate of vascular dementia.
- Glutamate Receptor Dysregulation and Platelet Glutamate Dynamics in Alzheimer's and Parkinson's Diseases: Insights into Current Medicationsby Deepa Gautam on November 25, 2023
Two of the most prevalent neurodegenerative disorders (NDDs), Alzheimer's disease (AD) and Parkinson's disease (PD), present significant challenges to healthcare systems worldwide. While the etiologies of AD and PD differ, both diseases share commonalities in synaptic dysfunction, thereby focusing attention on the role of neurotransmitters. The possible functions that platelets may play in neurodegenerative illnesses including PD and AD are becoming more acknowledged. In AD, platelets have been...
- Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptomsby Barbara Vuic on November 25, 2023
Dementia is a syndrome of global and progressive deterioration of cognitive skills, especially memory, learning, abstract thinking, and orientation, usually affecting the elderly. The most common forms are Alzheimer's disease, vascular dementia, and other (frontotemporal, Lewy body disease) dementias. The etiology of these multifactorial disorders involves complex interactions of various environmental and (epi)genetic factors and requires multiple forms of pharmacological intervention, including...